A phase I trial of BNC105P and ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia.
| Autor: | Pooler, Darcy B., Ness, Dylan B., Danilov, Alexey V., Labrie, Bridget M., Tosteson, Tor D., Eastman, Alan, Lewis, Lionel D., Lansigan, Frederick |
|---|---|
| Zdroj: | EJHaem; Nov2022, Vol. 3 Issue 4, p1445-1448, 4p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|